rss
Br J Ophthalmol 84:1250-1254 doi:10.1136/bjo.84.11.1250
  • Original Article
    • Clinical science

Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timololv 0.12% unoprostone

Table 4

Changes in corneal epithelial area, barrier function, and tear function tests in eyes with diabetes mellitus and dry eye

Weeks Timolol Unoprostone
DM/DE (+) DM/DE (−) DM/DE (+) DM/DE (−)
BUT (s) 0 6.80 (2.4) 7.33 (4.4) 5.71 (2.6) 7.77 (3.9)
12 6.25 (1.0) 6.09 (3.8) 5.50 (3.3) 7.56 (5.2)
24 5.00 (1.0) 4.50 (3.4) 8.20 (5.2) 6.78 (2.7)
Schirmer's test (mm/5 min) 0 13.8 (5.3) 12.1 (9.4) 13.9 (10.2) 17.7 (11.6)
12 10.8 (5.6) 9.00 (3.9) 13.2 (12.4) 19.3 (10.9)
24 10.0 (2.0) 7.00 (2.9) 15.2 (11.9) 16.6 (9.0)
Tear clearance test (log2) 0 2.20 (0.8) 3.20 (1.0) 3.71 (1.9) 3.25 (1.5)
12 1.00 (0.8) 3.20 (1.1) 4.00 (1.6) 3.33 (1.3)
24 1.67 (2.08) 2.38 (1.1) 4.60 (1.7) 3.64 (1.6)
Tear function index 0 31.6 (18.5) 43.9 (44.5) 56.1 (70.6) 59.1 (49.5)
12 10.3 (8.2) 29.6 (18.0) 65.4 (82.4) 56.7 (48.6)
24 16.0 (21.2) 17.8 (14.0) 81.0 (78.6) 53.9 (38.2)
  • p=0.0044,

  • p=0.011, compared with the value of the DM/DE (+) in the timolol group.

  • BUT = tear film break up time; DM = diabetes mellitus; DE = dry eye.

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.